我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- EKF Diagnostics Holdings plc has appointed Gavin Jones as Chief Executive Officer with immediate effect, promoting him from his previous role as Chief Product Officer. - Jones brings over twenty years of experience in point-of-care and life sciences, having led product management, R&D, marketing and regulatory departments at EKF since 2013. - The company reported revenues of £50.2m for 2024 with adjusted EBITDA climbing 9.2% to £11.3m, reflecting a strategic shift toward higher-margin products and services. - Founder Julian Baines will remain as Executive Chair and emphasized Jones' ambitious plans for delivering sustainable growth and unlocking unrealized potential in core products.
